Chiral selective effects of doxazosin enantiomers on blood pressure and urinary bladder pressure in anesthetized rats

Acta Pharmacologica Sinica

Volumn 27, Issue 11, 2006, Pages 1423-1430

  Ma, Shi Ping ^a   Ren, Lei Ming ^a   Zhao, Ding ^a   Zhu, Zhong Ning ^a   Wang, Miao ^a   Lu, Hai Gang ^b   Duan, Li Hua ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Professional College in Chemical and Pharmaceutical Sciences   (China)

Author keywords

Blood pressure; R doxazosin; Rat; S doxazosin; Urinary bladder pressure; Ventricular pressure

Indexed keywords

DOXAZOSIN;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLADDER PRESSURE; BLOOD PRESSURE; CAROTID ARTERY; CHIRALITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ENANTIOMER; HEART LEFT VENTRICLE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RACEMIZATION; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXAZOSIN; HEART RATE; MALE; PRESSURE; RATS; RATS, WISTAR; STEREOISOMERISM; URINARY BLADDER; VENTRICULAR PRESSURE;

EID: 33750294088     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00443.x     Document Type: Article

References (16)

1. Lepor H, Baumann M, Shapiro E. Binding and functional properties of doxazosin in the human prostate adenoma and canine brain. Prostate 1990; 16: 29-38.
2. Perlberg S, Caine M. Adrenergic response of bladder muscle in prostatic obstruction. Its relation to detrusor instability. Urology 1982; 20: 524-7.
3. Hatano A, Tang R, Walden PD, Lepor H. The α-adrenoceptor antagonist properties of the enantiomers of doxazosin in human prostate. Eur J Pharmacol 1996; 313: 135-43.
4. Yang ZH, Ren LM, Wu ZJ, Fu SX, Li YS. Selective effects of alfuzosin and doxazosin with intraduodenal administration on urethral pressure of cats. Acta Pharmacol Sin 1999; 20: 431-4.
5. 1-Adrenoceptor antagonist profile of doxazosin and its enantiomers in isolated rabbit blood vessels. Chin J Pharmacol Toxicol 2003; 17: 354-9.
6. Sun L, Rao MR, Liu PQ. Effects of praeruptorin C on cardiac dysfunction, myocardial compliance and collagen content in renovascular hypertensive rats. Acta Pharm Sin 1997; 32: 578-82.
7. Myers RA, Plym MJ, Signor LJ, Lodge NJ. 1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat. Neurourol Urodyn 2004; 23: 709-15.
8. Angelico P, Velasco C, Guarneri L, Sironi G, Leonardi A, Testa R. Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions. BMC Pharmacol 2005; 5: 14.
9. 1 adrenoceptor function in health and disease from transgenic animal studies. Trends Endocrinol Metab 2003; 14: 107-13.
10. 1B-adrenoceptor subtypes in rat common carotid arteries. Jpn J Pharmacol 2002; 88: 146-50.
11. Shen H, Peri KG, Deng XF, Chemtob S, Varma DR. Distribution of alpha1-adrenoceptor subtype proteins in different tissues of neonatal and adult rats. Can J Physiol Pharmacol 2000; 78: 237-43.
12. Oades GM, Eaton JD, Kirby RS. The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia. Curr Urol Rep 2000; 1: 97-102.
13. Ishizuka O, Persson K, Mattiasson A, Naylor A, Wyllie M, Andersson K. Micturition in conscious rats with and without bladder outlet obstruction: role of spinal alpha1-adrenoceptors. Br J Pharmacol 1996; 117: 962-6.
14. de Groat WC. Anatomy of the central neural pathways controlling the lower urinary tract. Eur Urol 1998; 34 (suppl 1): 2-5.
15. Somogyi GT, Tanowitz M, de Groat WC. Prejunctional facilitatory alpha1-adrenoceptors in the rat urinary bladder. Br J Pharmacol 1995; 114: 1710-6.
16. 1 adrenoceptors. Br J Pharmacol 2000; 130: 1685-91.